Galera Therapeutics, Inc. GRTX OTC

Other OTC • Healthcare • Biotechnology • US • USD

Galera Therapeutics, Inc. (GRTX) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 6 Buy, 3 Hold.

GRTX Analyst Ratings

Buy

Ratings

6 Buy

3 Hold

Based on 9 analysts giving stock ratings to Galera Therapeutics, Inc. in the past 3 months

Rating breakdown

Buy

6 67%

Hold

3 33%

67%

Buy

6 analysts

33%

Hold

3 analysts

Sell

0 analysts

People Also View

TERN

Terns Pharmaceuticals, Inc.

$52.71

+0.06%

DAWN

Day One Biopharmaceuticals, Inc.

$21.47

+0.05%

AMLX

Amylyx Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc.

$2.72

+1.49%

PDSB

PDS Biotechnology Corporation

$1.36

+28.30%

MREO

Mereo BioPharma Group plc

$0.34

+2.98%

XFOR

X4 Pharmaceuticals, Inc.

$4.33

+3.10%

Galera Therapeutics, Inc. GRTX OTC

GRTX Analyst Ratings

People Also View

Get Undervalued Stock Alerts